Autopsy report · NCT00889421
Apremilast in the Treatment of Uveitis
Cause of deathFutility
“Investigator discretion due to lack of efficacy in three subjects enrolled”
Life of this trial
- Registered 7 months before it started.
- Ran for about 1 year 7 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Oregon Health and Science University
- Sponsor type
- University, hospital or other
- Conditions
- Uveitis
- Interventions
- Apremilast
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
“The investigators decided not to proceed with this study” - Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
“The study was closed due to investigator discretion based on the lack of perceived clinical activity observed in the study.” - A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
“Lack of efficacy determined at interim analysis” - Compressive Stockings Therapy After TKA
“not enough study participants and missing compliance to perform analysis” - A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
“This study was terminated due to limited efficacy and not due to safety reasons”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.